US FDA plans September meeting to discuss IOM proposal to scrap 510(k)
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration is to hold a public meeting on 16 September to discuss the controversial Institute of Medicine report that calls for the agency to replace the pre-market notification process it uses to clear most medium- and low-risk medical devices with an entirely new framework1.